Director, CMC Analytical

NewAmsterdam Pharma Corporation•Remote - Massachusetts, MA

3d•Remote

About The Position

The Director, CMC Analytical is responsible for executing the analytical development strategy to support NewAmsterdam Pharma's clinical-stage and late-stage development programs. The Director will provide strategic and technical leadership for analytical development, quality control, and regulatory support activities across the product lifecycle, registration-enabling activities, pre-commercial readiness, and potential post-approval lifecycle management. This role will oversee analytical activities for active pharmaceutical ingredients (API) and drug products (DP), ensuring robust support for manufacturing, regulatory submissions, inspection readiness, and future commercial supply.

Requirements

PhD in analytical chemistry or a related field with at least 12 years of analytical team leadership in the biotechnology or pharmaceutical industry
Experience managing and building strong relationships with contract manufacturing organizations
Experience in early and late-stage programs, commercialization, commercial product support, launch transition, post-approval commitments, and life cycle management
Extensive technical expertise in analytical method development and validation for API and DP, characterization, and stability of solid oral dose
Proficiency in reviewing and analyzing release and stability data for trending, shelf-life, and specification establishment
Thorough understanding of ICH, FDA, and EMA guidance and GMP requirements governing product/process development and manufacture, and stability
Proficient in writing RFPs, protocols, reports, and regulatory documents
Exceptional interpersonal, negotiation, problem-solving, communication, and analytical skills
Must be well-organized, proactive, and detail-oriented
Demonstrates voracious intellectual curiosity, innovation, and creative problem-solving with an entrepreneurial spirit and a keen sense of urgency; can thrive in an agile environment
Ability to thrive in a fast-paced, high-growth, matrixed startup biotechnology environment while balancing strategic thinking with operational excellence and hands-on execution across both clinical and commercial asset needs
Project management skills including the ability to manage multiple projects; assess interpersonal relationships across multiple disciplines in product development; identify gaps that may impact critical milestones; assess, adjust, and maintain timelines as required by project needs; and evaluate project resources
Strong verbal and written communication skills with an ability to build relationships internally and externally
Willingness to travel to various meetings or client sites, domestically or internationally when necessary

Responsibilities

Spearhead the strategic direction and execution of analytical development, quality control, and analytical lifecycle activities for active pharmaceutical ingredients (API) and drug products (DP), supporting programs through registration, launch readiness, and potential post-approval activities.
Provide technical leadership and guidance to analytical development work, methods, and testing activities at CDMO
Oversee the establishment of testing methodology, specifications, and stability programs for raw materials, intermediates, excipients, APIs and DPs including trend analysis, and retesting strategy
Provide analytical leadership to support regulatory approval, commercial launch preparation, process validation, continued process verification, specification lifecycle management, and post-approval changes
Oversee API and DP release and stability testing as well as analytical regulatory documentation to support global clinical studies, commercial product stewardship, lifecycle management, post-approval commitments, and regulatory filings
Author, review, and strategically contribute to regulatory filings (including INDs, IMPDs, NDAs, briefing packages, and other regulatory dossiers)
Author and review technical documents, staying abreast of industry trends, regulations, and best practices
Drive the adoption of innovative technologies and quality-by-design (QbD) approaches
Review and approve analytical methods, specifications, change controls, deviation, investigation, out-of-trend, or out-of-specification reports
Work in close collaboration and support with other members of the CMC team responsible for API and DP development, as well as Clinical, Regulatory, Quality, Supply Chain, Technical Operations, and Commercial colleagues, to prioritize analytical activities across clinical-phase and commercial assets and support management as necessary